-
-
Call more information
660-596-2224 -
The opioid epidemic is fuelling growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections, according to a commentary published in the Journal of Infectious Diseases. Infectious disease and substance use disorder professionals must work together to stem the mounting public health threat, according to Tara A. Schwetz, PhD, […]
Read MoreBy Nancy A. Melville The extended-release local anaesthetic liposomal bupivacaine, commonly used in various surgical sites in adults, shows safety and efficacy in children and adults alike for control of pain with neurosurgery, according to a study presented here at the 2019 Annual Meeting of the American Association of Neurological Surgeons (AANS). “Our findings show […]
Read MoreAnesthesiology News Jay M. Mirtallo, MS, RPh, BCNSP, FASHP, FASPEN Professor Emeritus The Ohio State University College of Pharmacy Columbus, Ohio Malnutrition is a condition seen all over the world, not just in developing nations. In the United States, food deserts (areas without access to high-quality food) exist in rural and urban areas alike, affecting […]
Read MoreBy Erik MacLaren, PhD Intranasal ketamine produces favourable results in the treatment of patients with cancer-related pain, according to a small, ongoing, prospective study presented here at the 35th Annual Meeting of the American Academy of Pain Medicine (AAPM). More than half of patients with cancer experience pain, and opioid analgesics are limited by undesirable […]
Read MoreI wanted to share this since all men if they live long enough will develop prostate cancer. The FDA has approved darolutamide (Nubeqa) — a novel androgen-receptor inhibitor — to treat nonmetastatic, castration-resistant prostate cancer (cancer that continues to progress despite very low testosterone levels). Approval was based on a phase 3 clinical trial, published […]
Read More